Metabolic Syndrome is a combination of medical disorders that, when occurring together, increase the risk of developing cardiovascular disease and diabetes. According to the World Health Organization at least 285 million people worldwide have diabetes today. This number is expected to reach 500 million by 2030. The pathophysiology of metabolic syndrome is extremely complex and remains only partially explained. With the rising clinical failure rate for drugs targeting diabetes and other metabolic syndromes, there is an urgent need for better preclinical evaluation system which closely represents human disease biology.
At Crown Bioscience, we firmly believe the virtue of vigorous examination of biological pathways and drug mechanism of action in well defined biological systems which is translatable to human disease. Leveraging on the teachings gained from various clinical research and our access to unique animal models, large clinical tissue collection, and comprehensive database, we strive to redefine the translational research in this important disease area, and provide enabling solutions for those who seek the next ground-breaking therapeutics.
Copyright © 1999-2011 Crown Bio Science Inc. All Rights Reserved. - TEL:+1.855.827.6968 | Login